Report Overview
Report Overview
Infectious disease doctors test your blood or other body fluids to look for specific antibodies — cells produced by our immune system to fight harmful foreign substances. These tests can indicate what kind of infection is present. For bacterial infections, treatment usually involves antibiotics. Launch of mobile & self-testing devices has increased access to testing and monitoring systems to the remote places where the provision of timely medical care is a challenge.According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The global Point of Care Infectious Disease Testing market size was estimated at USD 3023.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Point of Care Infectious Disease Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Point of Care Infectious Disease Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Point of Care Infectious Disease Testing market.
Global Point of Care Infectious Disease Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Alere
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens Healthineers
BD
Chembio Diagnostics
Trinity Biotech
Cardinal Health
Quest Diagnostics
Bio-Rad Labs
bioMérieux
Sight Diagnostics
Gene POC
Trivitron Healthcare
OJ-Bio
Ortho-Clinical Diagnostics
Market Segmentation (by Type)
HIV POC
HBV POC
Pneumonia or Streptococcus Associated Infections
Respiratory Syncytial Virus (RSV) POC
HPV POC
Influenza POC
Others
Market Segmentation (by Application)
Hospitals
Clinics
Home
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Point of Care Infectious Disease Testing Market
Overview of the regional outlook of the Point of Care Infectious Disease Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Point of Care Infectious Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Point of Care Infectious Disease Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Point of Care Infectious Disease Testing
- 1.2 Key Market Segments
- 1.2.1 Point of Care Infectious Disease Testing Segment by Type
- 1.2.2 Point of Care Infectious Disease Testing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Point of Care Infectious Disease Testing Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Point of Care Infectious Disease Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Point of Care Infectious Disease Testing Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Point of Care Infectious Disease Testing Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Point of Care Infectious Disease Testing Product Life Cycle
- 3.3 Global Point of Care Infectious Disease Testing Sales by Manufacturers (2020-2025)
- 3.4 Global Point of Care Infectious Disease Testing Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Point of Care Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Point of Care Infectious Disease Testing Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Point of Care Infectious Disease Testing Market Competitive Situation and Trends
- 3.8.1 Point of Care Infectious Disease Testing Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Point of Care Infectious Disease Testing Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Point of Care Infectious Disease Testing Industry Chain Analysis
- 4.1 Point of Care Infectious Disease Testing Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Point of Care Infectious Disease Testing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Point of Care Infectious Disease Testing Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Point of Care Infectious Disease Testing Market
- 5.7 ESG Ratings of Leading Companies
- 6 Point of Care Infectious Disease Testing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Point of Care Infectious Disease Testing Sales Market Share by Type (2020-2025)
- 6.3 Global Point of Care Infectious Disease Testing Market Size by Type (2020-2025)
- 6.4 Global Point of Care Infectious Disease Testing Price by Type (2020-2025)
- 7 Point of Care Infectious Disease Testing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Point of Care Infectious Disease Testing Market Sales by Application (2020-2025)
- 7.3 Global Point of Care Infectious Disease Testing Market Size (M USD) by Application (2020-2025)
- 7.4 Global Point of Care Infectious Disease Testing Sales Growth Rate by Application (2020-2025)
- 8 Point of Care Infectious Disease Testing Market Sales by Region
- 8.1 Global Point of Care Infectious Disease Testing Sales by Region
- 8.1.1 Global Point of Care Infectious Disease Testing Sales by Region
- 8.1.2 Global Point of Care Infectious Disease Testing Sales Market Share by Region
- 8.2 Global Point of Care Infectious Disease Testing Market Size by Region
- 8.2.1 Global Point of Care Infectious Disease Testing Market Size by Region
- 8.2.2 Global Point of Care Infectious Disease Testing Market Size by Region
- 8.3 North America
- 8.3.1 North America Point of Care Infectious Disease Testing Sales by Country
- 8.3.2 North America Point of Care Infectious Disease Testing Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Point of Care Infectious Disease Testing Sales by Country
- 8.4.2 Europe Point of Care Infectious Disease Testing Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Point of Care Infectious Disease Testing Sales by Region
- 8.5.2 Asia Pacific Point of Care Infectious Disease Testing Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Point of Care Infectious Disease Testing Sales by Country
- 8.6.2 South America Point of Care Infectious Disease Testing Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Point of Care Infectious Disease Testing Sales by Region
- 8.7.2 Middle East and Africa Point of Care Infectious Disease Testing Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Point of Care Infectious Disease Testing Sales by Region
- 9 Point of Care Infectious Disease Testing Market Production by Region
- 9.1 Global Production of Point of Care Infectious Disease Testing by Region(2020-2025)
- 9.2 Global Point of Care Infectious Disease Testing Revenue Market Share by Region (2020-2025)
- 9.3 Global Point of Care Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Point of Care Infectious Disease Testing Production
- 9.4.1 North America Point of Care Infectious Disease Testing Production Growth Rate (2020-2025)
- 9.4.2 North America Point of Care Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Point of Care Infectious Disease Testing Production
- 9.5.1 Europe Point of Care Infectious Disease Testing Production Growth Rate (2020-2025)
- 9.5.2 Europe Point of Care Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Point of Care Infectious Disease Testing Production (2020-2025)
- 9.6.1 Japan Point of Care Infectious Disease Testing Production Growth Rate (2020-2025)
- 9.6.2 Japan Point of Care Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Point of Care Infectious Disease Testing Production (2020-2025)
- 9.7.1 China Point of Care Infectious Disease Testing Production Growth Rate (2020-2025)
- 9.7.2 China Point of Care Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Alere
- 10.1.1 Alere Basic Information
- 10.1.2 Alere Point of Care Infectious Disease Testing Product Overview
- 10.1.3 Alere Point of Care Infectious Disease Testing Product Market Performance
- 10.1.4 Alere Business Overview
- 10.1.5 Alere SWOT Analysis
- 10.1.6 Alere Recent Developments
- 10.2 Thermo Fisher Scientific
- 10.2.1 Thermo Fisher Scientific Basic Information
- 10.2.2 Thermo Fisher Scientific Point of Care Infectious Disease Testing Product Overview
- 10.2.3 Thermo Fisher Scientific Point of Care Infectious Disease Testing Product Market Performance
- 10.2.4 Thermo Fisher Scientific Business Overview
- 10.2.5 Thermo Fisher Scientific SWOT Analysis
- 10.2.6 Thermo Fisher Scientific Recent Developments
- 10.3 F. Hoffmann-La Roche
- 10.3.1 F. Hoffmann-La Roche Basic Information
- 10.3.2 F. Hoffmann-La Roche Point of Care Infectious Disease Testing Product Overview
- 10.3.3 F. Hoffmann-La Roche Point of Care Infectious Disease Testing Product Market Performance
- 10.3.4 F. Hoffmann-La Roche Business Overview
- 10.3.5 F. Hoffmann-La Roche SWOT Analysis
- 10.3.6 F. Hoffmann-La Roche Recent Developments
- 10.4 Siemens Healthineers
- 10.4.1 Siemens Healthineers Basic Information
- 10.4.2 Siemens Healthineers Point of Care Infectious Disease Testing Product Overview
- 10.4.3 Siemens Healthineers Point of Care Infectious Disease Testing Product Market Performance
- 10.4.4 Siemens Healthineers Business Overview
- 10.4.5 Siemens Healthineers Recent Developments
- 10.5 BD
- 10.5.1 BD Basic Information
- 10.5.2 BD Point of Care Infectious Disease Testing Product Overview
- 10.5.3 BD Point of Care Infectious Disease Testing Product Market Performance
- 10.5.4 BD Business Overview
- 10.5.5 BD Recent Developments
- 10.6 Chembio Diagnostics
- 10.6.1 Chembio Diagnostics Basic Information
- 10.6.2 Chembio Diagnostics Point of Care Infectious Disease Testing Product Overview
- 10.6.3 Chembio Diagnostics Point of Care Infectious Disease Testing Product Market Performance
- 10.6.4 Chembio Diagnostics Business Overview
- 10.6.5 Chembio Diagnostics Recent Developments
- 10.7 Trinity Biotech
- 10.7.1 Trinity Biotech Basic Information
- 10.7.2 Trinity Biotech Point of Care Infectious Disease Testing Product Overview
- 10.7.3 Trinity Biotech Point of Care Infectious Disease Testing Product Market Performance
- 10.7.4 Trinity Biotech Business Overview
- 10.7.5 Trinity Biotech Recent Developments
- 10.8 Cardinal Health
- 10.8.1 Cardinal Health Basic Information
- 10.8.2 Cardinal Health Point of Care Infectious Disease Testing Product Overview
- 10.8.3 Cardinal Health Point of Care Infectious Disease Testing Product Market Performance
- 10.8.4 Cardinal Health Business Overview
- 10.8.5 Cardinal Health Recent Developments
- 10.9 Quest Diagnostics
- 10.9.1 Quest Diagnostics Basic Information
- 10.9.2 Quest Diagnostics Point of Care Infectious Disease Testing Product Overview
- 10.9.3 Quest Diagnostics Point of Care Infectious Disease Testing Product Market Performance
- 10.9.4 Quest Diagnostics Business Overview
- 10.9.5 Quest Diagnostics Recent Developments
- 10.10 Bio-Rad Labs
- 10.10.1 Bio-Rad Labs Basic Information
- 10.10.2 Bio-Rad Labs Point of Care Infectious Disease Testing Product Overview
- 10.10.3 Bio-Rad Labs Point of Care Infectious Disease Testing Product Market Performance
- 10.10.4 Bio-Rad Labs Business Overview
- 10.10.5 Bio-Rad Labs Recent Developments
- 10.11 bioMérieux
- 10.11.1 bioMérieux Basic Information
- 10.11.2 bioMérieux Point of Care Infectious Disease Testing Product Overview
- 10.11.3 bioMérieux Point of Care Infectious Disease Testing Product Market Performance
- 10.11.4 bioMérieux Business Overview
- 10.11.5 bioMérieux Recent Developments
- 10.12 Sight Diagnostics
- 10.12.1 Sight Diagnostics Basic Information
- 10.12.2 Sight Diagnostics Point of Care Infectious Disease Testing Product Overview
- 10.12.3 Sight Diagnostics Point of Care Infectious Disease Testing Product Market Performance
- 10.12.4 Sight Diagnostics Business Overview
- 10.12.5 Sight Diagnostics Recent Developments
- 10.13 Gene POC
- 10.13.1 Gene POC Basic Information
- 10.13.2 Gene POC Point of Care Infectious Disease Testing Product Overview
- 10.13.3 Gene POC Point of Care Infectious Disease Testing Product Market Performance
- 10.13.4 Gene POC Business Overview
- 10.13.5 Gene POC Recent Developments
- 10.14 Trivitron Healthcare
- 10.14.1 Trivitron Healthcare Basic Information
- 10.14.2 Trivitron Healthcare Point of Care Infectious Disease Testing Product Overview
- 10.14.3 Trivitron Healthcare Point of Care Infectious Disease Testing Product Market Performance
- 10.14.4 Trivitron Healthcare Business Overview
- 10.14.5 Trivitron Healthcare Recent Developments
- 10.15 OJ-Bio
- 10.15.1 OJ-Bio Basic Information
- 10.15.2 OJ-Bio Point of Care Infectious Disease Testing Product Overview
- 10.15.3 OJ-Bio Point of Care Infectious Disease Testing Product Market Performance
- 10.15.4 OJ-Bio Business Overview
- 10.15.5 OJ-Bio Recent Developments
- 10.16 Ortho-Clinical Diagnostics
- 10.16.1 Ortho-Clinical Diagnostics Basic Information
- 10.16.2 Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Product Overview
- 10.16.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Product Market Performance
- 10.16.4 Ortho-Clinical Diagnostics Business Overview
- 10.16.5 Ortho-Clinical Diagnostics Recent Developments
- 10.1 Alere
- 11 Point of Care Infectious Disease Testing Market Forecast by Region
- 11.1 Global Point of Care Infectious Disease Testing Market Size Forecast
- 11.2 Global Point of Care Infectious Disease Testing Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Point of Care Infectious Disease Testing Market Size Forecast by Country
- 11.2.3 Asia Pacific Point of Care Infectious Disease Testing Market Size Forecast by Region
- 11.2.4 South America Point of Care Infectious Disease Testing Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Point of Care Infectious Disease Testing by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Point of Care Infectious Disease Testing Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Point of Care Infectious Disease Testing by Type (2026-2035)
- 12.1.2 Global Point of Care Infectious Disease Testing Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Point of Care Infectious Disease Testing by Type (2026-2035)
- 12.2 Global Point of Care Infectious Disease Testing Market Forecast by Application (2026-2035)
- 12.2.1 Global Point of Care Infectious Disease Testing Sales (K Units) Forecast by Application
- 12.2.2 Global Point of Care Infectious Disease Testing Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Point of Care Infectious Disease Testing Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings